← Back to Patent Explorer
US5829447A Expired / Lapsed US ⏱️ 0.0 years remaining

Method and apparatus for thoracoscopic intracardiac procedures

Assignee: Heartport Inc
•
Filing: 1996-05-07
•
Granted: 1998-11-03
•
Expires: 2016-05-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Devices, systems, and methods are provided for accessing the interior of the heart and performing procedures therein while the heart is beating. In one embodiment, a tubular access device having an inner lumen is provided for positioning through a penetration in a muscular wall of the heart, the access device having a means for sealing within the penetration to inhibit leakage of blood through the penetration. The sealing means may comprise a balloon or flange on the access device, or a suture placed in the heart wall to gather the heart tissue against the access device. An obturator is removably positionable in the inner lumen of the access device, the obturator having a cutting means at its distal end for penetrating the muscular wall of the heart. The access device is preferably positioned through an intercostal space and through the muscular wall of the heart. Elongated instruments may be introduced through the tubular access device into an interior chamber of the heart to perform procedures such as septal defect repair and electrophysiological mapping and ablation. A method of septal defect repair includes positioning a tubular access device percutaneously through an intercostal space and through a penetration in a muscular wall of the heart, passing one or more instruments through an inner lumen of the tubular access device into an interior chamber of the heart, and using the instruments to close the septal defect. Devices and methods for closing the septal defect with either sutures or with patch-type devices are disclosed.

Inventors

  • 👤 John H. Stevens
  • 👤 Bruce A. Reitz

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-22 20:13
CPC Classifications
A; A61; A61B; A61B17/00; A61B17/00234; A61B17/0057; A61B17/02; A61B17/0218; A61B17/04; A61B17/0469; A61B17/06; A61B17/06061; A61B17/32; A61B17/320016; A61B17/34; A61B17/3468; A61B18/00; A61B18/04; A61B18/12; A61B18/14; A61B18/1482; A61B18/1492; A61B90/00; A61B90/50; A61F; A61F2/00; A61F2/02; A61F2/24; A61F2/2427; A61M; A61M25/00; A61M25/10; A61M25/1011; A61M39/00; A61M39/02; A61M39/0247; A61B17/0467; A61B17/28; A61B17/29; A61B17/2909; A61B17/3209; A61B17/3211; A61B17/3417; A61B18/1442; A61B2017/00017; A61B2017/00022; A61B2017/00039; A61B2017/00044; A61B2017/00048; A61B2017/00053; A61B2017/00238; A61B2017/00243; A61B2017/00247; A61B2017/00349; A61B2017/00575; A61B2017/00579; A61B2017/00592; A61B2017/00597; A61B2017/00606; A61B2017/00619; A61B2017/00623; A61B2017/00831; A61B2017/00867; A61B2017/00902; A61B2017/00907; A61B2017/0237; A61B2017/0243; A61B2017/047; A61B2017/0472; A61B2017/0474; A61B2017/0475; A61B2017/2926; A61B2017/2932; A61B2017/2943; A61B2017/2946; A61B17/30; A61B2017/306; A61B17/3403; A61B2017/3405; A61B2017/348; A61B2017/3482; A61B2017/3484; A61B2017/3486; A61B2017/3492; A61B2018/00053; A61B2018/00214; A61B2018/0022; A61B2018/00232; A61B2018/0025; A61B2018/00261; A61B2018/00273; A61B2018/00291; A61B2018/00315; A61B2018/00345; A61B2018/00351; A61B2018/00363; A61B2018/00392; A61B2018/00571; A61B2018/00577; A61B2018/00636; A61B2018/00898; A61B2018/00982; A61B2018/1465; A61B90/36; A61B90/37; A61M25/01; A61M25/02; A61M2025/028; A61M2039/0279; A61M2039/0297; A61M2205/00; A61M2205/33; A61M2205/3331; A61M2205/3344; A61M2205/3355; A61M2205/36; A61M2205/366; Y; Y10; Y10S; Y10S623/00; Y10S623/902; Y10S623/904

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 195 words
A method of performing an electrophysiological ablating procedure to ablate cardiac tissue in an interior chamber of a patient's heart, the method comprising steps of: forming a first opening in a patient's chest, the first opening passing through the chest wall and into the patient's thoracic cavity; forming a second opening in the wall of the patient's heart, the second opening passing through the wall of the heart and into an interior chamber of the heart; providing a cardiac access device having a distal end and a lumen for receiving an electrophysiological instrument; positioning at least the distal end of the cardiac access device through the first and second openings and into the interior chamber of the heart; providing an electrophysiological ablating instrument comprising at least one electrode configured to deliver electrical current, the electrode being coupled to a source of electrical current; positioning the electrophysiological ablating instrument in the lumen of the cardiac access device so that at least the electrode extends out of the distal end of the cardiac access device; and contacting cardiac tissue with the electrode and delivering current to the tissue to ablate at least selected portions of the tissue.
Claim 2
Independent Claim 195 words
A method of performing an electrophysiological ablating procedure to ablate cardiac tissue in an interior chamber of a patient's heart, the method comprising steps of: forming a first opening in a patient's chest, the first opening passing through the chest wall and into the patient's thoracic cavity; forming a second opening in the wall of the patient's heart, the second opening passing through the wall of the heart and into an interior chamber of the heart; providing a cardiac access device having a distal end and a lumen for receiving an electrophysiological instrument; positioning at least the distal end of the cardiac access device through the first and second openings and into the interior chamber of the heart; providing an electrophysiological ablating instrument comprising at least one electrode configured to deliver electrical current, the electrode being coupled to a source of electrical current; positioning the electrophysiological ablating instrument in the lumen of the cardiac access device so that at least the electrode extends out of the distal end of the cardiac access device; and contacting cardiac tissue with the electrode and delivering current to the tissue to ablate at least selected portions of the tissue.
Claim 3
Independent Claim 33 words
The method of 1, wherein the electrode of the electrophysiological ablating instrument is coupled to a source of radiofrequency current, and the radiofrequency current is delivered to the cardiac tissue through the electrode.
Claim 4
Independent Claim 33 words
The method of 1, wherein the electrode of the electrophysiological ablating instrument is coupled to a source of radiofrequency current, and the radiofrequency current is delivered to the cardiac tissue through the electrode.
Claim 5
Dependent Claim 24 words
The method of claim 1, wherein the electrophysiological ablating instrument comprises a plurality of electrodes which contact and deliver current to the cardiac tissue.
Claim 6
Dependent Claim 48 words
The method of claim 1, wherein the first opening is formed in the chest wall so as to pass through an intercostal space between adjacent ribs, and the cardiac access device is positioned through the intercostal space and through the second opening in the wall of the heart.
Claim 7
Dependent Claim 19 words
The method of claim 4, wherein the patient's ribs and sternum remain substantially intact during each of said steps.
Claim 8
Dependent Claim 46 words
The method of claim 1, wherein said steps are carried out while the patient's heart is beating, and further comprising the step of forming a hemostatic seal between the cardiac access device and the wall of the heart to inhibit blood loss through the second opening.
Claim 9
Dependent Claim 29 words
The method of claim 1, further comprising the step of deflecting a distal end of the electrophysiological instrument to position the electrode adjacent an interior wall of the heart.
Claim 10
Independent Claim 201 words
A method of performing an electrophysiological mapping procedure in an interior chamber of a patient's heart, the method comprising steps of: forming a first opening in a patient's chest, the first opening passing through the chest wall and into the patient's thoracic cavity; forming a second opening in the wall of the patient's heart, the second opening passing through the wall of the heart and into an interior chamber of the heart; providing a cardiac access device having a distal end and a lumen for receiving an electrophysiological instrument; positioning at least the distal end of the cardiac access device through the first and second openings and into the interior chamber of the heart; providing an electrophysiological mapping instrument comprising at least two electrodes configured to contact cardiac tissue, the electrodes being coupled to a device for detecting electrical potential between the electrodes; positioning the electrophysiological mapping instrument in the lumen of the cardiac access device so that at least the electrodes extend out of the distal end of the cardiac access device; and contacting cardiac tissue with the electrodes on the electrophysiological mapping instrument and detecting the electrical potential between the electrodes to map conduction pathways in the cardiac tissue.
Claim 11
Independent Claim 201 words
A method of performing an electrophysiological mapping procedure in an interior chamber of a patient's heart, the method comprising steps of: forming a first opening in a patient's chest, the first opening passing through the chest wall and into the patient's thoracic cavity; forming a second opening in the wall of the patient's heart, the second opening passing through the wall of the heart and into an interior chamber of the heart; providing a cardiac access device having a distal end and a lumen for receiving an electrophysiological instrument; positioning at least the distal end of the cardiac access device through the first and second openings and into the interior chamber of the heart; providing an electrophysiological mapping instrument comprising at least two electrodes configured to contact cardiac tissue, the electrodes being coupled to a device for detecting electrical potential between the electrodes; positioning the electrophysiological mapping instrument in the lumen of the cardiac access device so that at least the electrodes extend out of the distal end of the cardiac access device; and contacting cardiac tissue with the electrodes on the electrophysiological mapping instrument and detecting the electrical potential between the electrodes to map conduction pathways in the cardiac tissue.
Claim 12
Dependent Claim 48 words
The method of claim 8, wherein the first opening is formed in the chest wall so as to pass through an intercostal space between adjacent ribs, and the cardiac access device is positioned through the intercostal space and through the second opening in the wall of the heart.
Claim 13
Dependent Claim 19 words
The method of claim 9, wherein the patient's ribs and sternum remain substantially intact during each of said steps.
Claim 14
Dependent Claim 46 words
The method of claim 8, wherein said steps are carried out while the patient's heart is beating, and further comprising the step of forming a hemostatic seal between the cardiac access device and the wall of the heart to inhibit blood loss through the second opening.
Claim 15
Dependent Claim 45 words
The method of claim 8, wherein the contacting step is carried out by moving the electrodes from a first position in which they are out of contact with the cardiac tissue to a second position in which they are in contact with the cardiac tissue.
Claim 16
Dependent Claim 49 words
The method of claim 12, wherein the electrophysiological instrument comprises an expandable mechanism supporting the electrodes, and the expandable mechanism is moved from a collapsed orientation to an expanded orientation to move the electrodes from the first position to the second position and into contact with the cardiac tissue.
Claim 17
Dependent Claim 90 words
The method of claim 8, further comprising, after said contacting step, steps of: providing an electrophysiological ablating instrument comprising at least one electrode configured to deliver electrical current, the electrode being coupled to a source of electrical current; positioning the electrophysiological ablating instrument in the lumen of the cardiac access device so that at least the electrode extends out of the distal end of the cardiac access device; and contacting cardiac tissue with the electrode and delivering current to the tissue to ablate at least selected portions of the tissue.

References Cited (Backward Citations)

US3124136A Cited
US3874388A Cited
CA1045304A Cited
US4007743A Cited
US4061135A Cited
US4345600A Cited
US4598698A Cited
US4605002A Cited
US4665906A Cited
US5067957A Cited
US4573473A Cited
US4621638A Cited
US4628937A Cited
US4822345A Cited
US4786155A Cited
US4779611A Cited
US4836204A Cited
US4915107A Cited
US5029574A Cited
US4960424A Cited
US4901721A Cited
US5053046A Cited
US4917089A Cited
US5192301A Cited
US5122122A Cited
US5358478A Cited
US5336182A Cited
US5209747A Cited
US5108420A Cited
US5345937A Cited
US5178133A Cited
US5338317A Cited
US5183464A Cited
US5361752A Cited
US5425357A Cited
US5450843A Cited
US5309896A Cited
US5402772A Cited
US5386817A Cited
US5451235A Cited
US5425744A Cited
US5328467A Cited
US5363861A Cited
US5397331A Cited
WO1993010714A1 Cited
US5147374A Cited
US5353783A Cited
US5400770A Cited
WO1993013712A1 Cited
US5334217A Cited
US5486193A Cited
US5383888A Cited
US5405360A Cited
US5411481A Cited
US5425737A Cited
US5318525A Cited
US5368592A Cited
US5314466A Cited
US5403328A Cited
US5188636A Cited
US5242457A Cited
EP0573273A2 Cited
US5391156A Cited
DE4222291C1 Cited
US5312341A Cited
US5403329A Cited
US5313943A Cited
US5309910A Cited
US5293869A Cited
US5330492A Cited
US5364351A Cited
US5275166A Cited
US5380291A Cited
US5421323A Cited
WO1994013211A1 Cited
US5284488A Cited
US5381794A Cited
US5409483A Cited
US5329927A Cited
US5334210A Cited
US5346459A Cited
US5383466A Cited
WO1995001190A1 Cited
US5425747A Cited
US5564440A Cited
US5358488A Cited
US5381795A Cited
US5507811A Cited
WO1995030374A1 Cited
US5433727A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2001-11-02 2002-05-04 2002-11-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2005-11-02 2006-05-04 2006-11-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2009-11-02 2010-05-04 2010-11-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag